A study published in the New England Journal of Medicine says a CT scan following a first venous thromboebolism event may not benefit in detecting cancer.
An NEJM study found that the prevalence of occult cancer was low among patients who had a first unprovoked venous thromboembolism, and routine screening with CT of the abdomen and pelvis was not clinically beneficial.
The study was conducted because unprovoked venous thromboembolism is thought of as an earliest sign of cancer, and up to 10% of patients with unprovoked venous thromboembolism receive a diagnosis of cancer within a year of the event and then gradually decreases. While the hypothesis is that early screening and intervention can reduce cancer-associated mortality, there's not enough data to support the practice. This has resulted in a wide variation in policy and clinical practice, write the authors. How intense should the intervention be and what should be included as a part of the screening strategy? These are some of the questions that remain unanswered.
In this study, the authors conducted a randomized clinical trial to assess the efficacy and safety of adding CT of the abdomen and pelvis to a limited screening strategy for occult cancer.
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis
April 23rd 2025Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.
Read More